CapsoVision (CV) Gross Margin (2024 - 2025)
CapsoVision's (CV) quarterly Gross Margin came in at 49.87% in Q4 2025, down 36.0% year-on-year from 77.93% in Q4 2024, and down 7.81% quarter-over-quarter from 54.1% in Q3 2025.
CapsoVision (CV) Gross Margin (2024 - 2025) Analysis & Trends
CapsoVision has disclosed Gross Margin across 2 years of filings, most recently posting 49.87% for Q4 2025.
- Gross Margin for Q4 2025 came in at 49.87%, down 36.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 52.12% (changed N/A YoY), and the FY2025 annual result was 52.92%, down 132.0% from the prior year.
- Gross Margin came in at 49.87% for Q4 2025 at CapsoVision, down from 54.1% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 56.0% in Q2 2024 to a low of 49.87% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 56.20% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 63.29% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 63.83% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 69.46% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 78.01% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 45.22% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 62.95% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 38.53% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 43.89% |
| 10 | CapsoVision | 161.82 Mn | 151.71 Mn | 1.95 Mn | 49.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 49.87% |
| Sep 30, 2025 | 54.10% |
| Jun 30, 2025 | 54.63% |
| Dec 31, 2024 | 50.23% |
| Sep 30, 2024 | 55.87% |
| Jun 30, 2024 | 56.00% |